U.S. efforts to lessen the health care system's reliance on China will be tested in the coming weeks and months as the virus rolls through China.
"While the situation has improved compared to the early stages of Covid back in 2020, the manufacturers and distributors are still facing shortages, long lead times and supply risks, combined with increased operational costs," said Vijay Mohan, a vice president at o9 Solutions, which provides supply chain management technology to health care companies."The new wave of Covid that has started to re-emerge will further amplify the challenges.
been relying on their network of Chinese contacts and analytical data, which so far haven't indicated any major issues. “There’s been a lot of adjusting going on by industry, which has already begun to calculate that in terms of their strategic interests, they needed to lessen their exposure in China and diversify. So it’s a different reality now,” said Morrison. “If this had happened at the front end of the pandemic, the impacts would have been bigger, but we’ve had three years of recalibration.”
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
China seeks to minimize COVID-19 risk during travel rushChina is seeking to minimize the possibility of a major new COVID-19 outbreak during this month's Lunar New Year travel rush following the end of most pandemic containment measures
Read more »
China’s latest COVID challenge: Lunar New Year holiday travel surgeChina is hoping to avoid an acceleration in the pace of new COVID cases during the Lunar New Year holiday.
Read more »
Pfizer in talks with China to market COVID-19 antiviral treatment: ReportChina is reportedly in discussions with Pfizer to secure a license for the U.S. drugmaker's COVID-19 antiviral Paxlovid amid a surge in cases in the mainland.
Read more »
Exclusive: China in talks with Pfizer for generic COVID drugChina is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm's COVID-19 antiviral drug Paxlovid in China, three sources told Reuters.
Read more »
As COVID surges in China, US begins testing more travelers | amNewYorkThe airport testing is part of the government's early warning system for detecting new variants, which began expanding recently in the wake of a COVID-19 surge in China.
Read more »
NY Fed says China's COVID woes are pressuring supply chainsDeclining world supply chain pressures are being challenged by new disruptions in China tied to the coronavirus pandemic, the New York Federal Reserve reported on Friday.
Read more »